Why Nuvama Retains Hold on Kotak Mahindra Bank but Stays Bullish on SBI Life Insurance
About Nuvama’s Latest Banking and Insurance Outlook
Nuvama Securities has released its Q2FY26 review covering two key financial institutions — Kotak Mahindra Bank and SBI Life Insurance. The brokerage highlighted contrasting performance trends, keeping a cautious stance on Kotak Mahindra Bank while maintaining confidence in SBI Life’s continued business momentum.
Kotak Mahindra Bank: Margin Pressure Continues
Nuvama retained a Hold rating on Kotak Mahindra Bank with a revised target price of ₹2,082 (up from ₹2,020). The quarter saw a Net Interest Margin (NIM) decline of 11 bps QoQ, underperforming peers that averaged an 8 bps drop. Despite softer NIM, operating expenses fell 3% QoQ, partially offsetting the weakness.
Slippages declined 10% QoQ, but this moderation was still lower than peers, extending Kotak’s trend of weaker NIM and slippage performance for the second consecutive quarter. The report notes that margin and asset quality trends will be critical to monitor amid intensifying competition.
SBI Life Insurance: Growth Momentum Intact
For SBI Life Insurance, Nuvama maintained a Buy rating with a target price of ₹2,320, reaffirming its positive stance after strong quarterly performance. The insurer posted a Total APE growth of 10% YoY, supported by a 6% rise in retail and a 55.8% surge in group business.
Value of New Business (VNB) margin improved by 118 bps YoY to 28%, while the VNB amount reached ₹1,660 crore — a 6% beat versus estimates. The ITC portfolio impact is expected to be manageable. For FY26, management guided for APE growth of 13–14% and VNB margins between 26–28%, reflecting steady structural performance.
Valuation and Investment Perspective
Nuvama slightly trimmed FY26E–28E VNB estimates for SBI Life while rolling forward valuation to Sep-27E. For Kotak Mahindra Bank, slower improvement in NIM and slippage metrics justifies the continued Hold stance. In contrast, SBI Life’s robust operating leverage and consistent profitability make it one of the preferred picks in the insurance segment.
Investors seeking moderate risk exposure can consider diversified financial portfolios with a bias toward insurers showing strong APE growth and high persistency ratios. On the banking front, conservative positioning remains advisable until NIM trends stabilize.
If you follow financial sector updates, you may also want to explore our real-time market calls here 👉 Nifty Tip | BankNifty Tip.
Investor Takeaway
Nuvama’s dual stance captures a key market reality — margin compression is weighing on select private banks even as insurers continue to compound value through operating leverage. Kotak’s operational efficiency and asset quality will decide re-rating potential, while SBI Life remains a structural compounding story within the Indian insurance space. Explore more detailed sector insights at Indian-Share-Tips.com, which is a SEBI Registered Advisory Services.
SEBI Disclaimer: The information provided in this post is for informational purposes only and should not be construed as investment advice. Readers must perform their own due diligence and consult a registered investment advisor before making any investment decisions. The views expressed are general in nature and may not suit individual investment objectives or financial situations.
